Augmenter of liver regeneration protects the kidney against ischemia-reperfusion injury by inhibiting necroptosis

References

• Linkermann A, Chen G, Dong G, et al. Regulated cell death in AKI. J Am Soc Nephrol. 2014;25(12):2689–2701.
   PubMed Web of Science ®Google Scholar
• Kurzhagen JT, Dellepiane S, Cantaluppi V, et al. AKI: an increasingly recognized risk factor for CKD development and progression. J Nephrol. 2020;33(6):1171–1187.
   PubMed Web of Science ®Google Scholar
• Kinsey GR, Sharma R, Okusa MD. Regulatory T cells in AKI. J Am Soc Nephrol. 2013;24(11):1720–1726.
   PubMed Web of Science ®Google Scholar
• Huang L, Liao X, Sun H, et al. Augmenter of liver regeneration protects the kidney from ischaemia‐reperfusion injury in ferroptosis. J Cell Mol Med. 2019;23(6):4153–4164.
   PubMed Web of Science ®Google Scholar
• Liao X, Zhang L, Chen G, et al. Augmenter of liver regeneration inhibits TGF-β1-induced renal tubular epithelial-to-mesenchymal transition via suppressing TβR II expression in vitro. Exp Cell Res. 2014;327(2):287–296.
   PubMed Web of Science ®Google Scholar
• Pu T, Liao XH, Sun H, et al. Augmenter of liver regeneration regulates autophagy in renal ischemia-reperfusion injury via the AMPK/mTOR pathway. Apoptosis. 2017;22(7):955–969.
   PubMed Web of Science ®Google Scholar
• Yan R, Li Y, Zhang L, et al. Augmenter of liver regeneration attenuates inflammation of renal ischemia/reperfusion injury through the NF-kappa B pathway in rats. Int Urol Nephrol. 2015;47(5):861–868.
   PubMed Web of Science ®Google Scholar
• Zhu D, Liao X, Huang W, et al. Augmenter of liver regeneration protects renal tubular epithelial cells from ischemia-reperfusion injury by promoting PINK1/Parkin-mediated mitophagy. Front Physiol. 2020;11:178.
   PubMed Web of Science ®Google Scholar
• Holler N, Zaru R, Micheau O, et al. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol. 2000;1:489–495.
   PubMed Web of Science ®Google Scholar
• Vandenabeele P, Galluzzi L, Vanden Berghe T, et al. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol. 2010;11(10):700–714.
   PubMed Web of Science ®Google Scholar
• Gao S, Huang X, Zhang Y, et al. Investigation on the expression regulation of RIPK1/RIPK3 in the retinal ganglion cells (RGCs) cultured in high glucose. Bioengineered. 2021;12(1):3947–3956.
   PubMed Web of Science ®Google Scholar
• Song S, Ding Y, Dai GL, et al. Sirtuin 3 deficiency exacerbates diabetic cardiomyopathy via necroptosis enhancement and NLRP3 activation. Acta Pharmacol Sin. 2020. DOI:10.1038/s41401-020-0490-7.
   Web of Science ®Google Scholar
• Dong Y, Sun Y, Huang Y, et al. Depletion of MLKL inhibits invasion of radioresistant nasopharyngeal carcinoma cells by suppressing epithelial-mesenchymal transition. Ann Transl Med. 2019;7(23):741.
   PubMed Web of Science ®Google Scholar
• Alvarez-Diaz S, Preaudet A, Samson AL, et al. Necroptosis is dispensable for the development of inflammation-associated or sporadic colon cancer in mice. Cell Death Differ. 2020. DOI:10.1038/s41418-020-00673-z.
   Web of Science ®Google Scholar
• Wu XN, Yang ZH, Wang XK, et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell Death Differ. 2014;21(11):1709–1720.
   PubMed Web of Science ®Google Scholar
• Feng S, Yang Y, Mei Y, et al. Cleavage of RIP3 inactivates its caspase-independent apoptosis pathway by removal of kinase domain. Cell Signal. 2007;19(10):2056–2067.
   PubMed Web of Science ®Google Scholar
• Lin Y, Devin A, Rodriguez Y, et al. Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis. Genes Dev. 1999;13(19):2514–2526.
   PubMed Web of Science ®Google Scholar
• Tristão VR, Gonçalves PF, Dalboni MA, et al. Nec-1 protects against nonapoptotic cell death in cisplatin-induced kidney injury. Ren Fail. 2012;34(3):373–377.
   PubMed Web of Science ®Google Scholar
• Lau A, Wang S, Jiang J, et al. RIPK3-mediated necroptosis promotes donor kidney inflammatory injury and reduces allograft survival. Am J Transplant. 2013;13(11):2805–2818.
   PubMed Web of Science ®Google Scholar
• Wu H, Ma J, Wang P, et al. HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol. 2010;21(11):1878–1890.
   PubMed Web of Science ®Google Scholar
• Xu Y, Ma H, Shao J, et al. A Role for Tubular Necroptosis in Cisplatin-Induced AKI. J Am Soc Nephrol. 2015;26(11):2647–2658.
   PubMed Web of Science ®Google Scholar
• Francavilla A, Hagiya M, Porter KA, et al. Augmenter of liver regeneration: its place in the universe of hepatic growth factors. Hepatology. 1994;20(3):747–757.
   PubMed Web of Science ®Google Scholar
• LaBrecque DR, Pesch LA. Preparation and partial characterization of hepatic regenerative stimulator substance (SS) from rat liver. J Physiol. 1975;248(2):273–284.
   PubMed Web of Science ®Google Scholar
• Gandhi CR. Augmenter of liver regeneration. Fibrogenesis Tissue Repair. 2012;5(1):10.
   PubMedGoogle Scholar
• Polimeno L, Pesetti B, De Santis F, et al. Decreased expression of the augmenter of liver regeneration results in increased apoptosis and oxidative damage in human-derived glioma cells. Cell Death Dis. 2012;3(4):e289.
   PubMed Web of Science ®Google Scholar
• Liao XH, Chen GT, Li Y, et al. Augmenter of liver regeneration attenuates tubular cell apoptosis in acute kidney injury in rats. Possible Mech. 2012;34. 590–599.
   Google Scholar
• Long RT, Peng JB, Huang LL, et al. Augmenter of liver regeneration alleviates renal hypoxia-reoxygenation injury by regulating mitochondrial dynamics in renal tubular epithelial cells. Mol Cells. 2019;42(12):893–905.
   PubMed Web of Science ®Google Scholar
• Brooks C, Wei Q, Cho SG, et al. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest. 2009;119(5):1275–1285.
   PubMed Web of Science ®Google Scholar
• Jiang GP, Liao YJ, Huang LL, et al. Effects and molecular mechanism of pachymic acid on ferroptosis in renal ischemia reperfusion injury. Mol Med Rep. 2021;23. DOI:10.3892/mmr.2020.11704
   Web of Science ®Google Scholar
• Huang LL, Long RT, Jiang GP, et al. Augmenter of liver regeneration promotes mitochondrial biogenesis in renal ischemia-reperfusion injury. Apoptosis. 2018;23(11–12):695–706.
   PubMed Web of Science ®Google Scholar
• Gameiro J, Marques F, and Jaljcck J. Nov 19. Long-term consequences of acute kidney injury: a narrative review. Clin Kidney J. 2020;143789–804.
   PubMed Web of Science ®Google Scholar
• Ibrahim S, Weiss T. Augmenter of liver regeneration: essential for growth and beyond. Cytokine Growth Factor Rev. 2019;45:65–80.
   PubMed Web of Science ®Google Scholar
• De Almagro MC, and Vucic D, et al. Necroptosis: pathway diversity and characteristics. Semin Cell Dev Biol. 2015;39:56–62.
   PubMed Web of Science ®Google Scholar
• Pasparakis M, Vandenabeele P. Necroptosis and its role in inflammation. Nat. 2015;517(7534):311–320.
   Web of Science ®Google Scholar
• Liu SS, Chen YY, Wang SX, et al. Protective effect of dabrafenib on renal ischemia-reperfusion injury in vivo and in vitro. Biochem Biophys Res Commun. 2020;522(2):395–401.
   PubMed Web of Science ®Google Scholar
• Shen B, Mei M, Pu Y, et al. Necrostatin-1 attenuates renal ischemia and reperfusion injury via meditation of HIF-1α/mir-26a/TRPC6/PARP1 signaling. Mol Ther Nucleic Acids. 2019;17:701–713.
   PubMedGoogle Scholar
• Liao XH, Zhang L, Liu Q, et al. Augmenter of liver regeneration protects kidneys from ischaemia/reperfusion injury in rats. Nephrol Dialysis Trans. 2010;25(9):2921–2929.
   PubMed Web of Science ®Google Scholar
• LaRocca TJ, Stivison EA, Mal-Sarkar T, et al. CD59 signaling and membrane pores drive Syk-dependent erythrocyte necroptosis. Cell Death Dis. 2015;6(5):e1773.
   PubMed Web of Science ®Google Scholar
• Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nat. 2002;418(6894):191–195.
   Web of Science ®Google Scholar
• Pefanis A, Ierino FL, Murphy JM, et al. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 2019;96(2):291–301.
   PubMed Web of Science ®Google Scholar
• Jun W, Benjanuwattra J, Chattipakorn SC, et al. Necroptosis in renal ischemia/reperfusion injury: a major mode of cell death? Arch Biochem Biophys. 2020;689:108433.
   PubMed Web of Science ®Google Scholar